favipiravir (active substance) - Ukraine

AVIGAN

The drug is used to treat new or re-emerging pandemic infections caused by the influenza virus if other antiviral agents have failed or were ineffective.

Form: tablets

Active substance	Dosage
favipiravir	200 mg

ATC: J05AX27

Manufacturer: TOYAMA FACTOR FUJIFILM Toyama Chemical Co., Ltd

COVIFLU

The drug is used to treat new or recurrent pandemic infections caused by the influenza virus if other antiviral agents have not helped or were ineffective.

Form: tablets, film-coated

Active substance	Dosage
favipiravir	200 mg

ATC: J05AX27

Manufacturer: Glenmark Pharmaceuticals Ltd.

FAVIPIRAVIR-MIKROKHIM

The drug is prescribed for the treatment of new or recurrent pandemic infections caused by the influenza virus, if other antiviral agents have not helped or were ineffective.

Form: tablets, film-coated

Active substance	Dosage
favipiravir	200 mg

ATC: J05AX27

Manufacturer: Microkhim LLC (laboratory of physico-chemical analysis and production control; production unit; laboratory of biological analysis; legal address; responsible for batch release, excluding batch control/testing)